Aytu BioPharma, Inc. (AYTU)

Aytu BioPharma Revenue

Aytu BioPharma had revenue of $13.89M in the quarter ending September 30, 2025, a decrease of -16.21%. This brings the company's revenue in the last twelve months to $63.70M, down -0.38% year-over-year. In the fiscal year ending June 30, 2025, Aytu BioPharma had annual revenue of $66.38M with 1.84% growth.

• Revenue (ttm): $63.70M
• Revenue Growth: -0.38%
• P/S Ratio: 0.25
• Revenue / Employee: $767,422
• Employees: 83
• Market Cap: 22.62M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	66.38M	1.20M	1.84%
Jun 30, 2024	65.18M	-42.22M	-39.31%
Jun 30, 2023	107.40M	10.73M	11.10%
Jun 30, 2022	96.67M	31.04M	47.29%
Jun 30, 2021	65.63M	38.00M	137.52%
Jun 30, 2020	27.63M	12.99M	88.73%
Jun 30, 2019	14.64M	7.32M	100.00%
Jun 30, 2018	7.32M	877.06K	13.61%
Jun 30, 2017	6.44M	1.32M	25.72%
Jun 30, 2016	5.12M	4.60M	878.85%
Jun 30, 2015	523.56K	522.56K	52,256.40%
Aug 31, 2014	1,000.00	-116.86K	-99.15%
Jun 30, 2014	117.86K	116.11K	6,634.74%
Aug 31, 2013	1.75K	-3.50K	-66.67%
Aug 31, 2012	5.25K	-	-
Aug 31, 2011	-	-	-
Aug 31, 2010	-	-	-
Aug 31, 2009	1.75K	-	-
Aug 31, 2008	-	-	-
Aug 31, 2007	-	-	-